← Leaderboards
Christopher G Willett
Massachusetts General Hospital
$1,606,805
Attributed
$1,606,805
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $295.7K · FY2010–14$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,606,805 · 2
By mechanism
P30$1,080,465 · 1
R21$526,340 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Michael V. Seiden$17,220,467
- Matthew Raymond Smith$3,230,660
- Miriam Antoinette Bredella$11,700,851
- Elizabeth Austen Lawson$10,040,997
- Jordan W Smoller$49,248,068
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchQuality AssuranceArchivesInstitutesProgramsOperationElectronicsCancer PatientInformation SystemsGrantDisorder By SiteMalignant NeoplasmsClinical TrialsMonitorEnrollmentConflict Of InterestDatabasesData ReportingDevicesAbstractingEnsureFundingProtocols DocumentationRandomized
Grant awards (7)
Clinical Trials$295,731
P30 · FY2014 · CA · contact PI
Clinical Trials$181,247
P30 · FY2013 · CA · contact PI
Clinical Trials$193,451
P30 · FY2012 · CA · contact PI
Clinical Trials$196,856
P30 · FY2011 · CA · contact PI
Clinical Trials$213,180
P30 · FY2010 · CA · contact PI
Angiogenic Profile of Rectal Cancer$261,229
R21 · FY2004 · CA
Angiogenic Profile of Rectal Cancer$265,111
R21 · FY2003 · CA